Compounds > methyl methanesulfonate

methyl methanesulfonate and olaparib

methyl methanesulfonate has been researched along with olaparib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Adam, D; Chan, FK; Davarnia, P; Herdegen, T; Kabelitz, D; Lange, A; Linkermann, A; Mathieu, S; Rittger, A; Schütze, S; Sosna, J; Thon, L; Voigt, S1
Doroshow, JH; Huang, SY; Ji, J; Morris, J; Murai, J; Pommier, Y; Renaud, A; Takeda, S; Teicher, B; Zhang, Y1
Begum, F; Hatch, GM; Hombach-Klonisch, S; Kalantari, F; Klonisch, T; Krishnan, SN; Kumar-Kanojia, A; Los, M; Medapati, MR; Natarajan, S; Thanasupawat, T; Xu, FY1
Li, DQ; Lu, DY; Lu, Q; Shao, ZM; Zhang, FL1
Arai, E; Cao, Z; Deb, M; Deraska, PV; Faryabi, RB; Greenberg, RA; Li, W; Li, Y; Mach, RH; Patankar, S; Puentes, L; Shao, Y; Shi, J; Verma, P; Zhou, Y1
Hirota, K; Ibrahim, MA; Masutani, M; Ooka, M; Sasanuma, H; Shimizu, N; Takeda, S; Tsuda, M; Yamada, K; Yamada, S1

Other Studies

6 other study(ies) available for methyl methanesulfonate and olaparib

ArticleYear
TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death.
    Cellular and molecular life sciences : CMLS, 2014, Volume: 71, Issue:2

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Calpain; Cathepsins; Cell Line; Ceramides; Free Radical Scavengers; Guanidines; HEK293 Cells; HeLa Cells; HT29 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MCF-7 Cells; Methyl Methanesulfonate; Mice; Necrosis; Nuclear Pore Complex Proteins; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptor-Interacting Protein Serine-Threonine Kinases; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Tumor Necrosis Factor-alpha

2014
Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib.
    Molecular cancer therapeutics, 2014, Volume: 13, Issue:2

    Topics: Adenosine Triphosphate; Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Fluorescence Polarization; Humans; Immunoblotting; Indoles; Inhibitory Concentration 50; Methyl Methanesulfonate; Molecular Structure; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Stereoisomerism; Temozolomide

2014
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells.
    Molecular oncology, 2019, Volume: 13, Issue:2

    Topics: Amino Acid Sequence; Animals; Apoptosis; AT-Hook Motifs; Cell Line, Tumor; Cell Respiration; Cell Survival; Cytoprotection; DNA Damage; Drug Resistance, Neoplasm; HMGA2 Protein; Humans; Methyl Methanesulfonate; Mice; Mitochondria; Nicotinamide Phosphoribosyltransferase; Phthalazines; Piperazines; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Binding; Triple Negative Breast Neoplasms

2019
USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
    Cancer medicine, 2019, Volume: 8, Issue:15

    Topics: Antineoplastic Agents; BRCA1 Protein; Cell Line, Tumor; Cyanoacrylates; Drug Resistance, Neoplasm; Gene Knockout Techniques; HEK293 Cells; HeLa Cells; Humans; MCF-7 Cells; Methyl Methanesulfonate; Neoplasms; Phthalazines; Piperazines; Pyridines; Ubiquitin Thiolesterase; Ubiquitination

2019
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells.
    Nature cell biology, 2021, Volume: 23, Issue:2

    Topics: BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Cell Proliferation; Chromatin; Chromatin Assembly and Disassembly; Chromosome Aberrations; CRISPR-Cas Systems; DNA Helicases; DNA Repair; DNA-Binding Proteins; Epistasis, Genetic; Genomic Instability; Green Fluorescent Proteins; Homologous Recombination; Humans; Methyl Methanesulfonate; Mutation; Phthalazines; Piperazines; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Domains

2021
XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA.
    Genes to cells : devoted to molecular & cellular mechanisms, 2022, Volume: 27, Issue:5

    Topics: Adenosine Diphosphate Ribose; Alkylating Agents; DNA; DNA Damage; DNA Repair; Methyl Methanesulfonate; Phthalazines; Piperazines; Poisons; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Temozolomide

2022